We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$945M
AUM Growth
+$66.7M
Cap. Flow
+$6.04M
Cap. Flow %
0.64%
Top 10 Hldgs %
68.38%
Holding
92
New
2
Increased
34
Reduced
45
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$18.2M
2
CL icon
Colgate-Palmolive
CL
+$2.85M
3
K
Kellanova
K
+$2.22M
4
BAX icon
Baxter International
BAX
+$1.48M
5
AMGN icon
Amgen
AMGN
+$1.37M

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$4.29M
2
ORCL icon
Oracle
ORCL
+$2.51M
3
PEP icon
PepsiCo
PEP
+$2.27M
4
SLB icon
SLB Ltd
SLB
+$2.14M
5
CLX icon
Clorox
CLX
+$1.92M

Sector Composition

Rank Sector Weight
1 Consumer Staples 46.52%
2 Healthcare 18.92%
3 Energy 9.17%
4 Industrials 5.89%
5 Financials 4.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
1
Walmart Inc
WMT
$893B
$291M 30.76%
10,151,613
-17,256
-0.2% -$466K
BMY icon
2
Bristol-Myers Squibb
BMY
$123B
$81.8M 8.66%
1,385,311
+323,008
+30% +$18.2M
XOM icon
3
ExxonMobil
XOM
$615B
$62.4M 6.61%
675,241
-13,135
-2% -$1.22M
PG icon
4
Procter & Gamble
PG
$347B
$57.9M 6.13%
636,097
+3,489
+0.6% +$307K
KO icon
5
Coca-Cola
KO
$353B
$54.6M 5.78%
1,293,468
-100,339
-7% -$4.29M
UPS icon
6
United Parcel Service
UPS
$96.2B
$32.4M 3.42%
291,035
-9,695
-3% -$1.02M
JNJ icon
7
Johnson & Johnson
JNJ
$599B
$27.1M 2.87%
258,858
-10,628
-4% -$1.12M
ABT icon
8
Abbott
ABT
$177B
$13.9M 1.47%
308,868
+12,150
+4% +$529K
CL icon
9
Colgate-Palmolive
CL
$73.6B
$13.5M 1.43%
195,319
+42,219
+28% +$2.85M
MSFT icon
10
Microsoft
MSFT
$2.99T
$11.8M 1.25%
254,203
+1,140
+0.5% +$53.5K
PFE icon
11
Pfizer
PFE
$141B
$11.5M 1.22%
388,537
+445
+0.1% +$12.8K
MRK icon
12
Merck
MRK
$307B
$10.9M 1.15%
200,449
+12,194
+6% +$679K
TFC icon
13
Truist Financial
TFC
$62.3B
$10.4M 1.1%
268,221
-17,419
-6% -$656K
CMCSA icon
14
Comcast
CMCSA
$84.9B
$9.91M 1.05%
341,528
-9,384
-3% -$257K
VFC icon
15
VF Corp
VFC
$6.62B
$9.19M 0.97%
130,249
+2,464
+2% +$163K
BAX icon
16
Baxter International
BAX
$11.4B
$8.95M 0.95%
224,762
+37,910
+20% +$1.48M
DIS icon
17
Walt Disney
DIS
$167B
$8.85M 0.94%
94,005
-6,190
-6% -$558K
TXN icon
18
Texas Instruments
TXN
$259B
$8.84M 0.94%
165,400
+21,150
+15% +$1.07M
JPM icon
19
JPMorgan Chase
JPM
$901B
$8.77M 0.93%
140,113
+11,735
+9% +$706K
VZ icon
20
Verizon
VZ
$182B
$8.57M 0.91%
183,325
-1,770
-1% -$86.6K
USB icon
21
US Bancorp
USB
$98.4B
$8.02M 0.85%
178,484
+4,890
+3% +$210K
LOW icon
22
Lowe's Companies
LOW
$115B
$7.94M 0.84%
115,368
+4,217
+4% +$252K
MXIM
23
DELISTED
Maxim Integrated Products
MXIM
$7.27M 0.77%
228,051
+3,300
+1% +$97K
PEP icon
24
PepsiCo
PEP
$185B
$6.4M 0.68%
67,641
-23,721
-26% -$2.27M
WMB icon
25
Williams Companies
WMB
$90.7B
$6.33M 0.67%
140,930
+9,200
+7% +$470K

Similar funds

Cullinan Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Cullinan Associates held 92 positions worth $945M, up 7.6% from $878M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Cullinan Associates's Q4 2014 filing shows 2 new, 34 increased, 45 reduced and 4 closed positions. Its largest new stake was Kellanova: 36,902 shares worth $2.27M. The largest sale was Coca-Cola, an estimated $4.29M.

By sector, the portfolio is most concentrated in Consumer Staples at 47% of assets, up from 46% a quarter earlier, followed by Healthcare and Energy.

  • Cullinan Associates's largest Q4 2014 buy was Kellanova: 36,902 shares worth $2.27M.
  • Cullinan Associates added most to Bristol-Myers Squibb in Q4 2014, an estimated $18.2M increase.
  • Cullinan Associates's biggest Q4 2014 reduction was Coca-Cola, cutting an estimated $4.29M.
  • Cullinan Associates fully exited Clorox in Q4 2014, selling an estimated $1.92M.
  • Cullinan Associates's ten largest holdings make up 68% of its $945M portfolio in Q4 2014.
  • Cullinan Associates opened 2 new positions and closed 4 in Q4 2014.
  • Cullinan Associates's portfolio value rose 7.6% quarter-over-quarter to $945M.

Based on Cullinan Associates's 13F filing for Q4 2014, filed 21 Jan 2015.